Barclays’s HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 HHLA.WS Stock Holding History

Barclays’s Portfolio HHLA.WS Stock Details HHLA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,000	Closed	-$250	–	5475
2023 Q4	$250	Hold	10,000	–	–	﹤0.01%	5150
2023 Q3	$340	Hold	10,000	–	–	﹤0.01%	4520
2023 Q2	$200	Hold	10,000	–	–	﹤0.01%	4418
2023 Q1	$103K	Hold	10,000	–	–	﹤0.01%	4155
2022 Q4	$501	Hold	10,000	–	–	﹤0.01%	5152
2022 Q3	$0	Buy	+10,000	New	+$767	﹤0.01%	5231

Barclays's HHLA.WS Position: Q1 2024 in Review

Barclays sold out of HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (HHLA.WS) in Q1 2024, closing a stake of 10,000 shares — an estimated $250 sold.

Barclays first reported a position in HHLA.WS in Q3 2022 and held it in 6 quarters. The position peaked at $103K in Q1 2023. 0 funds tracked by Wall St. Rank hold HHLA.WS as of Q1 2024.

Barclays reported no remaining HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2024 after selling out during the quarter.
Barclays sold 10,000 HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2024, an estimated $250.
Barclays first reported a position in HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2022 and held it in 6 quarters.
Barclays's HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $103K in Q1 2023.
0 funds tracked by Wall St. Rank held HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2024.

Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.